4-AMINO-10-AZATRICYCLO[6.3.1.02,7]DODECA-2(7),3,5-TRIENE HYDROCHLORIDE
- CAS230615-05-1
- CatalogueRS-U074141
- FormulaC11H14N2.HCl
- MW210.71
On this page
Product identification
| Product name | 4-AMINO-10-AZATRICYCLO[6.3.1.02,7]DODECA-2(7),3,5-TRIENE HYDROCHLORIDE |
|---|---|
| Catalogue No. | RS-U074141 |
| CAS No. | 230615-05-1 |
| Molecular formula | C11H14N2.HCl |
| Molecular weight | 210.71 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Fine Chemicals |
| Drug substance | Varenicline |
| Also known as | 1,5-Methano-1H-3-benzazepin-7-amine, 2,3,4,5-tetrahydro-, hydrochloride (1:1); Varenicline Tartrate Impurity 85 Hydrochloride |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-U074141 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Varenicline
- Fine Chemicals of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-U074141
- Request a quotation for RS-U074141
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Varenicline
All 45 further standards are listed here — every link is in the page, not loaded later.
-
Varenicline
IN STOCKRS-I057023 -
Varenicline Citrate
BACK ORDERRS-U007300 -
Varenicline Impurity D
IN STOCKRS-U004390 -
1,1-Diethylhydrazine
IN STOCKRS-U004AF2 -
1,2,4,5-tetrahydro-3H-1,5-methanobenzo[d]azepine-3-carbaldehyde
IN STOCKRS-V042018 -
1,4-DIethyl 2,3-dihydroxybutanedioate
BACK ORDERRS-U004AD0 -
1,4-DIHYDRO-1,4-METHANONAPHTHALENE
IN STOCKRS-U004ADJ -
1,4-Methanonaphthalene-2,3-diol, 1,2,3,4-tetrahydro-
CUSTOM SYNTHESISRS-U010A5N -
1,5,6,7,8,9-Hexahydro-5,9-methanoimidazo[4',5':4,5]benzo[1,2-d]azepine
CUSTOM SYNTHESISRS-V042015 -
2,2-Dihydroxyacetaldehyde
IN STOCKRS-Z401JWW -
2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine-7,8-diamine
IN STOCKRS-P010731 -
2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine Hydrochloride
IN STOCKRS-U016194 -
2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine
IN STOCKRS-D111119 -
2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine
IN STOCKRS-P010235 -
2-methyl-1,5,6,7,8,9-hexahydro-5,9-methanoimidazo[4',5':4,5]benzo[1,2-d]azepine
BACK ORDERRS-U053735 -
3-benzyl-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine
IN STOCKRS-U055158 -
4-(9,10-dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)butan-2-one
CUSTOM SYNTHESISRS-V042031 -
5,9-Methanoimidazo[4,5-h][3]benzazepine,1,5,6,7,8,9-hexahydro-,hydrochloride
IN STOCKRS-U015131 -
7,8-dinitro-3-nitroso-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine
IN STOCKRS-V042034 -
7-Nitro-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine
IN STOCKRS-V042014 -
9,10-dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-ol
IN STOCKRS-V042037 -
N-Hydroxy Varenicline
IN STOCKRS-U211MMK -
Varenicline 1-N-oxide
IN STOCKRS-V042004 -
Varenicline(Tartrate Salt)
IN STOCKRS-U007142 -
Varenicline Impurity 1
IN STOCKRS-Z412TVZ -
Varenicline Impurity 2
IN STOCKRS-V042008 -
Varenicline Impurity 8
CUSTOM SYNTHESISRS-V042005 -
Varenicline Impurity 10
IN STOCKRS-V042002 -
Varenicline Impurity 19 HCl
BACK ORDERRS-V042019 -
Varenicline Impurity 20
IN STOCKRS-V042009 -
Varenicline Impurity 22
IN STOCKRS-V042016 -
Varenicline Impurity 26
IN STOCKRS-V042013 -
Varenicline Impurity 35
IN STOCKRS-V042012 -
Varenicline Impurity 54
CUSTOM SYNTHESISRS-I001289 -
Varenicline Impurity 71
IN STOCKRS-U004691 -
Varenicline Impurity 72
IN STOCKRS-V042007 -
Varenicline Impurity 76
IN STOCKRS-V042003 -
Varenicline Impurity 77
IN STOCKRS-V042006 -
Varenicline Impurity 78
IN STOCKRS-V042010 -
Varenicline Impurity 79
IN STOCKRS-V042011
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.



![Chemical structure of (6R,10S)-6,7,9,10-Tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxaline-8-carboxylic Acid](/structures/w4/DPKXSOCWNABKSB-DTORHVGOSA-N.webp?v=8)

![Chemical structure of 1,2,4,5-tetrahydro-3H-1,5-methanobenzo[d]azepine-3-carbaldehyde](/structures/w4/XFJLZTNXPHRQBN-UHFFFAOYSA-N.webp?v=8)



![Chemical structure of 1,5,6,7,8,9-Hexahydro-5,9-methanoimidazo[4',5':4,5]benzo[1,2-d]azepine](/structures/w4/SPAMUHJHVULSFR-OCAPTIKFSA-N.webp?v=8)
![Chemical structure of 2,2,2-Trifluoro-1-(5,6,8,9-tetrahydro-5,9-methanoimidazo[4',5':4,5]benzo[1,2-d]azepin-7(1H)-yl)ethan-1-one](/structures/w4/ZMDSJUHTRFKMHF-UHFFFAOYSA-N.webp?v=8)



![Chemical structure of 2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine](/structures/w4/COMHUAMOJSTCMM-UHFFFAOYSA-N.webp?v=8)

![Chemical structure of 2,3-Dihydroxy-4-oxo-4-(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxalin-8-yl)butanoic acid](/structures/w4/ANLPQXPHGCEMKB-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2-methyl-1,5,6,7,8,9-hexahydro-5,9-methanoimidazo[4',5':4,5]benzo[1,2-d]azepine](/structures/w4/MYEQHDICIDYWIK-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 3-benzyl-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine](/structures/w4/TWQZMFJJYHNANK-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 4,6,7,8,9,10-Hexahydro-1H-6,10-methanoazepino[4,5-g]quinoxaline-2,3-dione Hydrochloride](/structures/w4/WPQFNRPPXPNQEK-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 4-(9,10-dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)butan-2-one](/structures/w4/ANQACYJRGBJMLE-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 5,9-Methanoimidazo[4,5-h][3]benzazepine,1,5,6,7,8,9-hexahydro-,hydrochloride](/structures/w4/PBSPGZCHJMECEE-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 6,7,8,9-tetrahydro-, monohydrochloride](/structures/w4/NZVVYNGXLGJKCW-DRJPZDRJSA-N.webp?v=8)
![Chemical structure of 7,8-dinitro-3-nitroso-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine](/structures/w4/XCIZXZBPVNWIAX-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 7-Nitro-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine](/structures/w4/AJJVWIGUUYROJX-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 9,10-dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-ol](/structures/w4/CDXUPQBYCZFMFP-UHFFFAOYSA-N.webp?v=8)
















